Brief: Harrow Inc Q4 Gross Margin 79%
02/03/2026 21:05
Mar 02 (Reuters) - Harrow Inc Q4 revenue USD 89.1 million vs. IBES estimate USD 88.4 million.
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates